JOURNAL OF LEUKOCYTE BIOLOGY, v.95, no.4, pp.621 - 629
Publisher
FEDERATION AMER SOC EXP BIOL
Abstract
PD-1 is a well-established negative regulator of T cell
responses by inhibiting proliferation and cytokine production
of T cells via interaction with its ligands,
B7-H1 (PD-L1) and B7-DC (PD-L2), expressed on
non-T cells. Recently, PD-1 was found to be expressed
in innate cells, including activated DCs, and
plays roles in suppressing production of inflammatory
cytokines. In this study, we demonstrate that PD-1 KO
DCs exhibited prolonged longevity compared with WT
DCs in the dLNs after transfer of DCs into hind footpads.
Interestingly, upon LPS stimulation, WT DCs increased
the expression of PD-1 and started to undergo
apoptosis. DCs, in spleen of LPS-injected PD-1
KO mice, were more resistant to LPS-mediated apoptosis
in vivo than WT controls. Moreover, treatment
of blocking anti-PD-1 mAb during DC maturation resulted
in enhanced DC survival, suggesting that PD-1:
PD-L interactions are involved in DC apoptosis. As a
result, PD-1-deficient DCs augmented T cell responses
in terms of antigen-specific IFN- production
and proliferation of CD4 and CD8 T cells to a greater
degree than WT DCs. Moreover, PD-1 KO DCs exhibited
increased MAPK1 and CD40–CD40L signaling,
suggesting a possible mechanism for enhanced DC
survival in the absence of PD-1 expression. Taken together,
our findings further extend the function of
PD-1, which plays an important role in apoptosis of
activated DCs and provides important implications
for PD-1-mediated immune regulation. J. Leukoc. Biol.
95: 621–629; 2014.